These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
4. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
5. The role of neuroleptics in manic-depressive illness. Kane JM J Clin Psychiatry; 1988 Nov; 49 Suppl():12-4. PubMed ID: 2903142 [TBL] [Abstract][Full Text] [Related]
6. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
8. Depot neuroleptics: side effects and safety. Marder SR J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089 [TBL] [Abstract][Full Text] [Related]
9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine in the treatment of acute mania: target dose for efficacious treatment. Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic features and effects of neuroleptics. Seeman MV Can Med Assoc J; 1981 Oct; 125(8):821-6. PubMed ID: 6118205 [TBL] [Abstract][Full Text] [Related]
12. Aripiprazole: new drug. Just another neuroleptic. Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic medication in the treatment of schizophrenia. Kane JM Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642 [TBL] [Abstract][Full Text] [Related]
14. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists. Heresco-Levy U; Brom D; Greenberg D Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study. Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645 [TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
18. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]